Centre for Cardiovascular and Lung Biology, Ninewells Hospital, Univ. of Dundee, Scotland, United Kingdom.
Am J Physiol Lung Cell Mol Physiol. 2010 Oct;299(4):L455-71. doi: 10.1152/ajplung.00348.2009. Epub 2010 Jul 9.
Lung development requires coordinated signaling between airway and vascular growth, but the link between these processes remains unclear. Mammalian target of rapamycin complex-1 (mTORC1) can amplify hypoxia-inducible factor-1α (HIF-1α) vasculogenic activity through an NH(2)-terminal mTOR binding (TOS) motif. We hypothesized that this mechanism coordinates vasculogenesis with the fibroblast growth factor (FGF)-10/FGF-receptor2b/Spry2 regulator of airway branching. First, we tested if the HIF-1α TOS motif participated in epithelial-mesenchymal vascular signaling. mTORC1 activation by insulin significantly amplified HIF-1α activity at fetal Po(2) (23 mmHg) in human bronchial epithelium (16HBE14o-) and induced vascular traits (Flk1, sprouting) in cocultured human embryonic lung mesenchyme (HEL-12469). This enhanced activation of HIF-1α by mTORC1 was abolished on expression of a HIF-1α (F99A) TOS-mutant and also suppressed vascular differentiation of HEL-12469 cocultures. Next, we determined if vasculogenesis in fetal lung involved regulation of mTORC1 by the FGF-10/FGFR2b/Spry2 pathway. Fetal airway epithelium displayed distinct mTORC1 activity in situ, and its hyperactivation by TSC1(-/-) knockout induced widespread VEGF expression and disaggregation of Tie2-positive vascular bundles. FGF-10-coated beads grafted into fetal lung explants from Tie2-LacZ transgenic mice induced localized vascular differentiation in the peripheral mesenchyme. In rat fetal distal lung epithelial (FDLE) cells cultured at fetal Po(2), FGF-10 induced mTORC1 and amplified HIF-1α activity and VEGF secretion without induction of ERK1/2. This was accompanied by the formation of a complex between Spry2, the cCBL ubiquitin ligase, and the mTOR repressor, TSC2, which abolished GTPase activity directed against Rheb, the G protein inducer of mTORC1. Thus, mTORC1 links HIF-1α-driven vasculogenesis with the FGF-10/FGFR2b/Spry2 airway branching periodicity regulator.
肺发育需要气道和血管生长之间的协调信号,但这些过程之间的联系仍不清楚。哺乳动物雷帕霉素靶蛋白复合物-1(mTORC1)可以通过 NH(2)末端 mTOR 结合(TOS)基序放大缺氧诱导因子-1α(HIF-1α)血管生成活性。我们假设这种机制将血管生成与成纤维细胞生长因子(FGF)-10/FGF-受体 2b/Spry2 气道分支调节剂协调起来。首先,我们测试了 HIF-1α TOS 基序是否参与上皮-间充质血管信号传递。胰岛素激活 mTORC1 在胎肺 Po(2)(23mmHg)显著放大了人支气管上皮(16HBE14o-)中的 HIF-1α 活性,并诱导了共培养的人胚胎肺间充质(HEL-12469)中的血管特征(Flk1,发芽)。mTORC1 对 HIF-1α 的这种增强激活在表达 HIF-1α(F99A)TOS 突变体时被消除,并且还抑制了 HEL-12469 共培养物的血管分化。接下来,我们确定了胎儿肺中的血管发生是否涉及 FGF-10/FGFR2b/Spry2 途径对 mTORC1 的调节。胎儿气道上皮在原位显示出明显的 mTORC1 活性,其 TSC1(-/-)敲除的过度激活诱导了广泛的 VEGF 表达和 Tie2 阳性血管束的离散。将 FGF-10 包被的珠粒移植到来自 Tie2-LacZ 转基因小鼠的胎儿肺外植体中,在周围间质中诱导了局部血管分化。在胎肺 Po(2)下培养的大鼠胎儿远端肺上皮(FDLE)细胞中,FGF-10 诱导了 mTORC1,并放大了 HIF-1α 活性和 VEGF 分泌,而没有诱导 ERK1/2。这伴随着 Spry2、cCBL 泛素连接酶和 mTOR 抑制剂 TSC2 之间形成复合物,该复合物消除了针对 Rheb 的 GTPase 活性,Rheb 是 mTORC1 的 G 蛋白诱导物。因此,mTORC1 将 HIF-1α 驱动的血管发生与 FGF-10/FGFR2b/Spry2 气道分支周期性调节剂联系起来。